Selected article for: "acute respiratory syndrome and long period"

Author: Wei, Zhi‐Yao; Qian, Hai‐Yan; Huang, Ji; Geng, Yong‐Jian
Title: Pathogenesis and Management of Myocardial Injury in Coronavirus Disease 2019
  • Cord-id: hqr2zskr
  • Document date: 2020_7_19
  • ID: hqr2zskr
    Snippet: The outbreak of coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, has become a major health crisis and a worldwide pandemic. COVID‐19 is characterized by high infectivity, long incubation period, diverse clinical presentations, and strong transmission intensity. COVID‐19 can cause myocardial injury as well as other cardiovascular complications, particularly in senior patients with pre‐existing medical conditions. Th
    Document: The outbreak of coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, has become a major health crisis and a worldwide pandemic. COVID‐19 is characterized by high infectivity, long incubation period, diverse clinical presentations, and strong transmission intensity. COVID‐19 can cause myocardial injury as well as other cardiovascular complications, particularly in senior patients with pre‐existing medical conditions. The current review summarizes the epidemiological characteristics, potential mechanisms, clinical manifestations, and recent progress in the management of COVID‐19 cardiovascular complications.

    Search related documents:
    Co phrase search for related documents
    • acei arb treatment and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7
    • acei arb treatment and lung liver: 1
    • acs acute coronary syndrome and acute coronary syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • acs acute coronary syndrome and acute heart failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acs acute coronary syndrome and acute myocarditis: 1, 2, 3, 4
    • acs acute coronary syndrome and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute coronary syndrome and low unfractionated heparin: 1
    • acute coronary syndrome and macro micro: 1
    • acute myocarditis and lung liver: 1
    • acute sars cov respiratory syndrome coronavirus and load reduction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
    • acute sars cov respiratory syndrome coronavirus and low unfractionated heparin: 1, 2, 3, 4, 5, 6, 7
    • acute sars cov respiratory syndrome coronavirus and low unfractionated heparin molecular weight heparin: 1, 2, 3, 4, 5
    • acute sars cov respiratory syndrome coronavirus and lowered risk: 1, 2, 3
    • acute sars cov respiratory syndrome coronavirus and lung liver: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47
    • acute sars cov respiratory syndrome coronavirus and macro micro: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • load reduction and lung liver: 1
    • low unfractionated heparin and macro micro: 1
    • lung liver and macro micro: 1